U.S. Strategy

Showing 6330 articles
Business

Michael Burry Bets on a GameStop Comeback, Defying Meme-Stock Skepticism

Famed 'Big Short' investor Michael Burry has taken a significant long position in GameStop, praising CEO Ryan Cohen's leadership while simultaneously hedging with bearish bets on tech giants Palantir and Nvidia. The move has reignited debate over the retailer's future and the influence of contrarian investors in volatile markets.

Business

EastGroup Properties: A Sunbelt REIT's Valuation Crossroads After Recent Gains

EastGroup Properties (EGP), a leading industrial REIT focused on the Sunbelt, has seen its shares climb to $180.44, delivering a solid one-year total return of 10.69%. This performance brings its valuation into sharp focus, with a narrative fair value estimate of $199.84 suggesting potential upside, yet a lofty P/E ratio of 38.7x signaling significant growth expectations priced in.

Business

Novo Nordisk's CagriSema Shows Superior Efficacy in Phase 3 Diabetes Trial, Bolstering Pipeline and Valuation Outlook

Novo Nordisk's combination therapy CagriSema has outperformed semaglutide in a pivotal Phase 3 trial for type 2 diabetes, significantly reducing blood sugar and weight. The strong results set the stage for regulatory discussions and reinforce the company's dominance in the metabolic treatment arena, amid heightened investor focus on its long-term growth potential.